These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31776649)

  • 21. Proton pump inhibitors not associated with hypomagnesemia, regardless of dose or concomitant diuretic use.
    Chowdhry M; Shah K; Kemper S; Zekan D; Carter W; McJunkin B
    J Gastroenterol Hepatol; 2018 Oct; 33(10):1717-1721. PubMed ID: 29514412
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Association between the Use of Proton Pump Inhibitors and the Risk of Hypomagnesemia in a National Cohort of Veteran Patients with HIV.
    Sutton SS; Magagnoli J; Cummings T; Hardin JW
    J Int Assoc Provid AIDS Care; 2019; 18():2325958218821652. PubMed ID: 30798693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of proton pump inhibitors and hypomagnesemia in the community setting.
    Markovits N; Loebstein R; Halkin H; Bialik M; Landes-Westerman J; Lomnicky J; Kurnik D
    J Clin Pharmacol; 2014 Aug; 54(8):889-95. PubMed ID: 24771616
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypomagnesemia and proton pump inhibitors: below the tip of the iceberg.
    Furlanetto TW; Faulhaber GA
    Arch Intern Med; 2011 Aug; 171(15):1391-2. PubMed ID: 21555654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical clues to magnesium deficiency.
    Cohen L; Kitzes R
    Isr J Med Sci; 1987 Dec; 23(12):1238-41. PubMed ID: 3440747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypomagnesaemia/hypokalemia associated with the use of esomeprazole.
    Negri AL; Valle EE
    Curr Drug Saf; 2011 Jul; 6(3):204-6. PubMed ID: 22122397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proton Pump Inhibitor Use and Magnesium Concentrations in Hemodialysis Patients: A Cross-Sectional Study.
    Nakashima A; Ohkido I; Yokoyama K; Mafune A; Urashima M; Yokoo T
    PLoS One; 2015; 10(11):e0143656. PubMed ID: 26618538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Relationship Between Resistant Tachycardia and Treatment for GERD.
    Elliott EM
    Explore (NY); 2016; 12(6):456-458. PubMed ID: 27693368
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proton Pump Inhibitor Prophylaxis After Gastric Bypass Does Not Cause Hypomagnesemia.
    Boerlage TC; van Hees CL; Huitema AD; Lauw FN
    Obes Surg; 2016 Mar; 26(3):688-90. PubMed ID: 26762281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse cardiovascular and blood pressure effects of drug-induced hypomagnesemia.
    Chrysant SG; Chrysant GS
    Expert Opin Drug Saf; 2020 Jan; 19(1):59-67. PubMed ID: 31795777
    [No Abstract]   [Full Text] [Related]  

  • 31. Oculogyric crisis in proton pump inhibitor-associated hypomagnesemia.
    Civardi C; Collini A; Geda C
    Parkinsonism Relat Disord; 2020 Mar; 72():80-81. PubMed ID: 32146379
    [No Abstract]   [Full Text] [Related]  

  • 32. Severe hypomagnesemia during long-term treatment with a proton pump inhibitor.
    Regolisti G; Cabassi A; Parenti E; Maggiore U; Fiaccadori E
    Am J Kidney Dis; 2010 Jul; 56(1):168-74. PubMed ID: 20493607
    [No Abstract]   [Full Text] [Related]  

  • 33. Low Prevalence of Hypomagnesemia in Long-term Recipients of Proton Pump Inhibitors in a Managed Care Cohort.
    Sharara AI; Chalhoub JM; Hammoud N; Harb AH; Sarkis FS; Hamadeh G
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):317-21. PubMed ID: 26499924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum magnesium and proton-pump inhibitors use: a cross-sectional study.
    Faulhaber GA; Ascoli BM; Lubini A; Mossmann M; Rossi G; Geib G; Furlanetto TW
    Rev Assoc Med Bras (1992); 2013; 59(3):276-9. PubMed ID: 23680271
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypomagnesaemia due to use of proton pump inhibitors--a review.
    Kuipers MT; Thang HD; Arntzenius AB
    Neth J Med; 2009 May; 67(5):169-72. PubMed ID: 19581665
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypomagnesemia induced by several proton-pump inhibitors.
    Broeren MA; Geerdink EA; Vader HL; van den Wall Bake AW
    Ann Intern Med; 2009 Nov; 151(10):755-6. PubMed ID: 19920278
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypomagnesemia and Hypocalcemia Caused by Proton-Pump Inhibitors Long-Term Therapy.
    Cabras P; Anedda M; Caddeo L; Francesco M; Antonella M
    Am J Ther; 2020; 27(6):e676-e680. PubMed ID: 31425160
    [No Abstract]   [Full Text] [Related]  

  • 38. Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study.
    Hess MW; de Baaij JH; Broekman MM; Bisseling TM; Haarhuis BJ; Tan AC; Te Morsche RH; Hoenderop JG; Bindels RJ; Drenth JP
    Pharmacogenet Genomics; 2017 Mar; 27(3):83-88. PubMed ID: 27926584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypocalcemia, hypomagnesemia, and hypokalemia following hydrofluoric acid chemical injury.
    Dalamaga M; Karmaniolas K; Nikolaidou A; Papadavid E
    J Burn Care Res; 2008; 29(3):541-3. PubMed ID: 18388571
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypomagnesemia Among Outpatient Long-Term Proton Pump Inhibitor Users.
    Biyik M; Solak Y; Ucar R; Cifci S; Tekis D; Polat İ; Göktepe MH; Sakiz D; Ataseven H; Demir A
    Am J Ther; 2017; 24(1):e52-e55. PubMed ID: 25353358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.